Recherche
-
Medications Recommended for Secondary Prevention After First Acute Coronary Syndrome: Effectiveness of Treatment Combinations in a Real-Life Setting
(Clinical Pharmacology and Therapeutics. vol. 103, n° 6, pp. 1038-1046, 2018-06)Article de revue -
Real-Life Benefits of Statins for Cardiovascular Prevention in Elderly Subjects: A Population-Based Cohort Study
(The American Journal of Medicine. vol. 132, n° 6, pp. 740-748 e7, 2019)Article de revue -
Systematic review on sex differences for drug use after stroke
(Fundamental and Clinical Pharmacology. vol. 36, pp. 111-111, 2022-06)Article de revue -
Chronic polypharmacy at all age: a population-based drug utilization study
(Fundamental and Clinical Pharmacology. vol. 36, n° 2, pp. 405-413, 2022-04)Article de revue -
Evaluation of Covid-19 vaccines: Pharmacoepidemiological aspects
(Thérapie. vol. 76, n° 4, pp. 305-309, 2021-05-07)Article de revue -
The Reply : Impact of Average Daily and Cumulative Dose of Statins on Mortality Risk Among Healthy Elderly
(The American Journal of Medicine. vol. 132, n° 7, pp. e622, 2019)Article de revue -
Drug-Drug Interactions and the Risk of Emergency Hospitalizations: A Nationwide Population-Based Study
(Drug Safety. vol. 46, n° 5, pp. 449-456, 2023-05)Article de revue -
Real-world effect of iloprost in patients with chronic limb-threatening ischemia (CLTI): A cohort study
(Vascular Medicine. pp. 1358863X231209263, 2023-11-07)Article de revue -
Systematic review on sex differences for drug use after stroke
(Therapies. vol. 78, pp. 213-224, 2023-03)Article de revue -
Response to Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390
(Diabetes Care. vol. 46, n° 5, pp. e121-e122, 2023-05-01)Article de revue